UiPath (NYSE:PATH) Trading Down 0.9%

Shares of UiPath Inc. (NYSE:PATH) dropped 0.9% during trading on Monday . The company traded as low as $18.49 and last traded at $18.58. Approximately 1,486,359 shares were traded during trading, a decline of 83% from the average daily volume of 8,816,817 shares. The stock had previously closed at $18.75.

Analyst Upgrades and Downgrades

PATH has been the subject of a number of research reports. Truist Financial reaffirmed a “buy” rating and set a $32.00 target price on shares of UiPath in a report on Wednesday, March 20th. Evercore ISI upped their target price on shares of UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a report on Thursday, March 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $29.00 target price on shares of UiPath in a report on Monday, April 1st. Bank of America increased their price objective on shares of UiPath from $26.00 to $30.00 and gave the stock a “buy” rating in a research note on Thursday, March 14th. Finally, DA Davidson increased their price objective on shares of UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a research note on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $27.41.

UiPath Price Performance

The company’s 50-day simple moving average is $22.55 and its 200 day simple moving average is $21.56. The firm has a market cap of $11.12 billion, a P/E ratio of -114.93 and a beta of 0.96.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 40,000 shares of the firm’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the sale, the chief financial officer now owns 660,762 shares in the company, valued at approximately $14,312,104.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In the last quarter, insiders sold 72,000 shares of company stock worth $1,591,360. 31.03% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Mark Sheptoff Financial Planning LLC purchased a new position in UiPath in the 4th quarter worth about $25,000. HighMark Wealth Management LLC purchased a new position in UiPath in the 4th quarter worth about $27,000. Cypress Capital Management LLC WY purchased a new position in UiPath in the 4th quarter worth about $29,000. GAMMA Investing LLC purchased a new position in UiPath in the 4th quarter worth about $36,000. Finally, FNY Investment Advisers LLC purchased a new position in UiPath in the 4th quarter worth about $40,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.